全球心血管器材市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計心血管器材市場將從 2025 年的 752.8 億美元成長到 2034 年的 1,518.6 億美元，2026 年至 2034 年的複合年成長率為 8.11%。

由於全球心血管疾病盛行率不斷上升以及醫療費用支出持續成長，全球心血管器材市場正經歷強勁成長。支架、心律調節器和診斷設備等心血管器械對於治療冠狀動脈疾病、心律不整和其他心臟疾病至關重要。人口老化和久坐的生活方式也顯著推動了市場需求。

關鍵成長要素包括微創手術和植入式醫療器材的技術進步。導管介入治療方法的普及和影像技術的改進正在提升治療效果。此外，人們對預防性心臟護理和早期診斷意識的提高，也促進了醫療器材在整個醫療保健系統中的廣泛應用。

展望未來，生物可吸收支架、穿戴式心臟監測設備和人工智慧輔助診斷技術等創新可望推動市場發展。新興國家醫療基礎設施的擴建將帶來新的成長機會。持續進行旨在提升設備安全性和耐用性的研發工作，將繼續有力地支持全球市場的擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球心血管器材市場：依器材類型分類

• 市場分析、洞察與預測
• 診斷和監測設備
• 治療及外科器械

第5章 全球心血管器材市場：依應用分類

• 市場分析、洞察與預測
• 冠狀動脈疾病（CAD）
• 心律不整
• 心臟衰竭
• 其他

第6章 全球心血管器材市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 專科診所
• 其他

第7章 全球心血管器材市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • B. Braun Melsungen AG
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Johnson & Johnson Services Inc
  • General Electric Company（GE Healthcare）
  • LivaNova PLC
  • Siemens Healthcare GmbH
  • Terumo Cardiovascular Systems Corporation

The Cardiovascular Devices Market size is expected to reach USD 151.86 Billion in 2034 from USD 75.28 Billion (2025) growing at a CAGR of 8.11% during 2026-2034.

The Global Cardiovascular Devices Market is experiencing robust growth due to rising prevalence of heart diseases and increasing healthcare expenditure worldwide. Cardiovascular devices, including stents, pacemakers, and diagnostic equipment, are essential in managing coronary artery disease, arrhythmias, and other heart conditions. Growing aging populations and sedentary lifestyles are contributing significantly to market demand.

Key growth drivers include technological advancements in minimally invasive procedures and implantable devices. Expansion of catheter-based interventions and improved imaging technologies are enhancing treatment outcomes. Additionally, growing awareness about preventive cardiac care and early diagnosis is supporting increased device utilization across healthcare systems.

Looking ahead, the market is expected to benefit from innovation in bioresorbable stents, wearable cardiac monitoring devices, and AI-assisted diagnostics. Expanding healthcare infrastructure in emerging economies will provide new growth avenues. Continuous research and development efforts aimed at improving device safety and longevity will likely sustain strong global market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Diagnostic and Monitoring Devices
• Therapeutic and Surgical Devices

By Application

• Coronary Artery Disease (CAD)
• Cardiac Arrhythmia
• Heart Failure
• Others

By End User

• Hospitals
• Specialty Clinics
• Others

COMPANIES PROFILED

• B Braun Melsungen AG, Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson Johnson Services Inc, General Electric Company GE Healthcare, LivaNova PLC, Siemens Healthcare GmbH, Terumo Cardiovascular Systems Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Diagnostic and Monitoring Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutic and Surgical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Coronary Artery Disease (CAD) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiac Arrhythmia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIOVASCULAR DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 B. Braun Melsungen AG
  • 9.2.2 Medtronic
  • 9.2.3 Abbott
  • 9.2.4 Boston Scientific Corporation
  • 9.2.5 Edwards Lifesciences Corporation
  • 9.2.6 Johnson & Johnson Services Inc
  • 9.2.7 General Electric Company (GE Healthcare)
  • 9.2.8 LivaNova PLC
  • 9.2.9 Siemens Healthcare GmbH
  • 9.2.10 Terumo Cardiovascular Systems Corporation